期刊文献+

AKT/FOXOs/Atrogin-1/MuRF1信号通路在慢性阻塞性肺疾病大鼠骨骼肌萎缩中的作用 被引量:7

Role of AKT/FOXOs/Atrogin-1/MuRF1 Signalling Pathway in Skeletal Muscle Atrophy in COPD Rats
下载PDF
导出
摘要 目的探讨AKT/FOXOs/Atrogin-1/MuRF1信号通路在慢性阻塞性肺疾病(COPD)大鼠骨骼肌萎缩中的作用。方法采用单纯熏香烟法复制COPD大鼠动物模型。采用逆转录-聚合酶链式反应(RT-PCR)和Western blot技术检测COPD大鼠伸趾长肌内E3连接酶的两个肌肉萎缩特异性指标Atrogin-1和MuRF1,以及其上游FOXOs转录因子的基因与蛋白表达的变化;对伸趾长肌中磷酸化AKT(p-AKT)的蛋白表达及其与总AKT(t-AKT)的蛋白表达比率进行测定。结果 RT-PCR分析结果显示,COPD大鼠伸趾长肌组织中的Atrogin-1的mRNA表达明显上调(P<0.01);MuRF1和FOXO-1的mRNA表达与对照组比较差异有统计学意义(P<0.05)。Western blot分析结果显示,伸趾长肌组织中Atrogin-1的蛋白相对表达量COPD组较对照组明显增加(P<0.01);MuRF1的蛋白表达COPD组较对照组增加(P<0.05);FOXO-1的蛋白表达两组比较无明显差异(P>0.05)。COPD组大鼠伸趾长肌中p-AKT的蛋白表达较对照组增加(P<0.05),p-AKT/t-AKT COPD组明显高于对照组(P<0.01)。结论 AKT/FOXOs/Atrogin-1/MuRF1信号通路参与COPD骨骼肌萎缩机制并发挥重要作用。 Objective To investigate the role of AKT/FOXOs/atrogin-1/MuRF1 signaling pathway in skeletal muscle atrophy in rats with chronic obstructive pulmonary diseases (COPD). Methods Passive cigarette smoking was used to establish COPD model. The protein expression of atrogin-1, MuRF1, FOXO-1, phosohorylated-AKT and total AKT were measured by Western blot. The mRNA expression of atrogin-1, MuRF1 and FOXO-1 were measured by reverse transeription-polymerase chain reaction (RT-PCR). Results Compared with the control group, the mRNA expressions of atrogin-1, MuRF1 and FOXO-1 significantly increased in extensor digitorum longus (EDL) of the COPD group ( P 〈 0. 05 ). Meanwhile the protein expression of atrogin-1 and MuRF1 significantly increased in the COPD group( P 〈 0.05 ),while the protein expression of FOXO-I was not significantly different between two groups (P 〉 0. 05 ). In addition,, the protein expression of phosohorylated-AKT and the ratio of phosohorylated-AKT to total AKT significantly increased in EDL of the COPD group ( P 〈 0. 05 ). Conclusion The mRNA and protein expression of AKT/FOXOs/ atrogin-1/MuRF1 in skeletal muscle are significantly increased in COPD rats, suggesting that AKT/FOXOs/ atrogin-1/MuRF1 signalling pathway plays a crucial role in skeletal muscle atrophy of COPD.
出处 《中国呼吸与危重监护杂志》 CAS 2013年第3期217-222,共6页 Chinese Journal of Respiratory and Critical Care Medicine
基金 上海市卫生局科研课题基金资助项目(编号:2010089)
关键词 慢性阻塞性肺疾病 AKT/FOXOs/Atrogin-1/MuRF1信号通路 大鼠 骨骼肌 萎缩 Chronic obstructive pulmonary diseases AKT/FOXOs/Atrogin-1/MuRF1 signaling pathway Rats Skeletal muscle Atrophy
  • 相关文献

参考文献16

  • 1Burtin C, Decramer M, Gosselink R, et al. Rehabilitation and acute exacerbations. Eur Respir J,2011,38:702-712.
  • 2Macklem PT. Therapeutic implications of the pathophysiology ofCOPD. Eur Respir J,2010,35:676-680.
  • 3Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J,2009,33 : 1165-1185.
  • 4Debigar6 R ,Marquis K, C8t6 CI-I, et al. Catabolic/anabolic balance and muscle wasting in patients with COPD. Chest, 2003, 124: 83 -89.
  • 5李红梅,崔德健,佟欣,庞宝森,高亚兵,王德文.熏香烟加气管注内毒素和单纯熏香烟法建立大鼠COPD模型[J].中国病理生理杂志,2002,18(7):808-812. 被引量:105
  • 6马学军,舒跃龙,译校.精编分子生物学实验指南.第4版,北京:科学出版社,2005,378-416.
  • 7Raguso CA, Luthy C. Nutritional status in chronic obstructive pulmonary disease : role of hypoxia. Nutrition ,2011,27 : 138-143.
  • 8McKinnell IW, Rudnicki MA. Molecular mechanisms of muscle atrophy. Ce11,2004,119:907-910.
  • 9Ottenheijm CA, Heunks LM, Li YP, et al. Activation of the ubiquitin-proteasome pathway in the diaphragm in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2006, 174:997-1002.
  • 10韩锋锋,罗勇,徐卫国.慢性阻塞性肺疾病大鼠骨骼肌组织泛素系统基因及蛋白表达的变化[J].上海医学,2008,31(8):571-574. 被引量:10

二级参考文献36

  • 1Wray C J, Sun X, Gang GJ, et al. Dantrolene downregulates the gene expression and activity of the ubiquitin-proteasome proteolytic pathway in septic skeletal muscle. J Surg Res,2002,104:82-87.
  • 2Ausubel MF,Brent R,Konston ER,et al.马学军,舒跃龙,译校.精编分子生物学实验指南.第4版.北京:科学出版社,2005,378-416.
  • 3Ezzell L, Jensen G1. Malnutrition in chronic obstructive pulmonary disease. Am J Clin Nutr,2000,72 : 1415-1416.
  • 4Laaban JP. Nutrition and chronic respiratory failure. Ann Inter Med, 2000,151:542-548.
  • 5Jagoe RT, Engelen MP. Muscle wasting and changes in muscle protein metabolism in chronic obstructive pulmonary disease. Eur Respir J ,2003,46:52s-63s.
  • 6Rutten EP, Franssen FM, Engelen MP, et al. Greater whole,body myofibfillar protein breakdown incachectic patients with chronic obstructive pulmonary disease. Am J Clin Nutr,2006,83(4) :829-834.
  • 7Laghi F, Tobin MJ. Disorders of the respiratory muscles. Am J Respir Crit Care Med,2003,168 : 10-48.
  • 80ttenheijm CAC, Heunks LMA, Hafmans T, et al. Titin and diaphragm dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med,2006,173:527-534.
  • 9Barreiro E, de la Puente B, Minguella J, et al. Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med,2005,171:1116-1124.
  • 10Levine S, Nguyen T, Kaiser LR, et al. Human diaphragm remodeling associated with chronic obstructive pulmonary disease: clinical implications. Am J Respir Crit Care Med ,2003,168:706-713.

共引文献121

同被引文献96

  • 1宋采秋,马贤德,束沛,刘昱麟,曲妮妮.都气丸合参苓白术散加减治疗慢性阻塞性肺疾病临床观察[J].辽宁中医药大学学报,2020,0(2):207-210. 被引量:17
  • 2杨旭辉,朱敏恒,吴越.植物源性天然抗氧化成分研究进展[J].农垦医学,2004,26(4):298-300. 被引量:20
  • 3赵亚丽,孙圣华,刘纯,周妍,唐文祥.COPD营养不良与细胞因子的关系及消炎痛干预实验研究[J].医学临床研究,2006,23(10):1572-1574. 被引量:10
  • 4Kim HC, Mofarrahi M, Hussain SN. Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease. Int J Chmn Obstruct Pulmon Dis,2008,3:637-658.
  • 5Sandri M. Signaling in muscle atrophy and hypertrophy. Physiology ( Bethesda), 2008,23 : 160-170.
  • 6Toker A, Cantley LC. Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature, 1997,387 : 673-676.
  • 7Maehama T, Dixon JE. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem, 1998,273 : 13375-13378.
  • 8Hirai K,Hayashi T,Chan PH,et al. PI3K in hibition inneonatal rat brain slices during and after hypoxia reduces phospho-Akt and increases cytosolie eytochrome e and apoptosis. Brain Res Mol Brain Res ,2004 ,124 :51-61.
  • 9Nojima H, Tokunaga C, Egnchi S, et al. The mammalian target of rapamycin (mTOR) partner,raptor,binds the roTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling(TOS) motif. J Biol Chem,2003,278 : 15461-15464.
  • 10Vyas DR, Spangenburg EE, Abraha TW, et al. GSK-313 negatively regulates skeletal myotube hypertrophy. Am J Physiol, 2002,283 : 545 -551.

引证文献7

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部